How to value an early-stage startup: methods and when each applies

Early-stage valuation is part art and mostly negotiation, but a few methods help anchor the conversation. None of these is the right answer in isolation; founders and investors use them as triangulation. The VC method works backward from an exit valuation. The Scorecard method benchmarks against comparable angel rounds. The Berkus method assigns dollar values to milestones. DCF is rarely useful pre-revenue but disciplines unit economics. Comparable transactions provide market evidence when data is available.

Estimate exit value (e.g., USD 200 million in 5-7 years), divide by target investor multiple (typically 10x for early-stage investors), giving exit valuation needed (USD 20 million). Discount that to present value at investor IRR (typically 50-70%) and subtract future dilution. For a 5-year hold at 50% IRR, divide by 7.6. Result: post-money valuation. Sensitivities: exit value assumption (most companies do not exit at USD 200 million), multiple expectation, and dilution assumptions. The VC method gives one anchor; layer others on top.

Pick an average pre-money valuation for comparable angel-round startups in your geography and stage (e.g., USD 8 million for a seed SaaS in tier-1 Indian markets). Adjust up or down based on weighted factors: team strength (30%), size of opportunity (25%), product/technology (15%), competitive environment (10%), marketing/sales/partnerships (10%), need for additional investment (5%), other (5%). A strong team in a large market with proven product can push above the average by 25-50%. Weak team in crowded market discounts 25-40%. Used widely by US angels.

Assign value (up to USD 500,000 each) for: sound idea (base value), prototype (reducing technology risk), quality management team (reducing execution risk), strategic relationships (reducing market risk), and product rollout or sales (reducing production risk). Maximum pre-money valuation of USD 2.5 million using this method. Useful for very early pre-revenue startups where other methods break down. The dollar caps are dated for 2026 (designed for 1990s-2000s valuations); modern adaptations scale up by 2-4x.

DCF (discounted cash flow) requires a defensible revenue and cost projection. Most early-stage startups cannot defend a 5-year projection, making DCF outputs meaningless. DCF is useful as a discipline (does the company need to be USD 50 million in revenue at year 5 for the valuation to hold?) rather than as a primary method. Comparables (precedent transactions, revenue multiples) work if you have credible data: recent seed/Series A in your sector and geography, deal multiples on revenue or users. Investors increasingly demand a comparables sheet, even early-stage.

What is the most common method investors actually use?
Investors rarely use a single method explicitly. They benchmark recent comparable rounds in their network, apply gut-feel adjustments for team and traction, and target an ownership percentage (typically 15-25%) for the cheque size they want to write. The valuation is the math that follows.

How do I justify a USD 30 million pre-money for my seed?
Combine: strong founder pedigree (prior exits, deep domain), demonstrable traction (early revenue, design partners, retention), large addressable market, scarcity (multiple investor interest), and recent comparable rounds at similar valuations. No single method produces USD 30 million; the negotiation produces it.

Is a 409A valuation different from this?
Yes. 409A is a regulatory valuation for US tax purposes (setting the exercise price of stock options to avoid Section 409A penalties). It is performed by a third-party valuation firm and is typically lower than the most recent priced-round valuation. 409A is a compliance number; this guide is about negotiation valuation.

How does ESOP pool top-up affect valuation?
If a lead investor requires a 10-15% option-pool top-up pre-money, the effective pre-money to founders is lower. Example: headline pre-money USD 10 million but with a 10% top-up, the founder dilution math treats the pre-money as approximately USD 9 million. Negotiate the pool size against the actual hiring plan.

Should I tell investors my desired valuation upfront?
Mixed views. Some founders quote a range and let lead investors anchor. Others let investors come back with term sheets. The current consensus: in competitive rounds with multiple interested investors, let them anchor; in cold-start rounds, anchor early to filter for fit.

Do convertible notes and SAFEs reduce valuation pressure?
Yes. They defer the valuation conversation to the priced round. The cap is a negotiation but a softer one than priced-round valuation. Founders increasingly raise on SAFE for pre-seed and seed, then negotiate priced valuation only at Series A.